| Model Number |
N/A |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/17/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been returned to the manufacturer for evaluation.
|
| |
|
Event or Problem Description
|
|
It was reported by customer that during the continuous administration of blinatumomab, the tubing is cracking at the distal section of port tubing just above the q-site.Additional information received 10/23/2024: it was reported by the customer patient was receiving blinatumomab in the outpatient setting when the port line cracked and required readmission to the hospital overnight to be re-accessed and a new bag of chemotherapy initiated.Crack resulted in treatment delay, inability for patient to receive total drug ordered and unnecessary procedure.
|
| |
|
Search Alerts/Recalls
|